How many institutions held CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in Q2 2018?

37 institutional investors reported CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share for Q2 2018. Use the holders table for investor-level position and value details.

Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

Q: What does CUSIP 22978P106 represent in this 13F holders report?

CUSIP 22978P106 is the security identifier for CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 22978P106

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 43,411,663
Total 13F shares: 3,148,586
Share change: +1,305,231
Total reported value: $37,344,175
Price per share: $11.86
Number of holders: 37
Value change: +$15,445,827
Number of buys: 30
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 22978P106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
First Eagle Investment Management, LLC	13F	Company	1.2%	500,000	$7,025,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	1%	451,863	$6,349,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	0.91%	394,827	$5,547,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.27%	118,010	$1,658,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.17%	75,153	$1,056,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	71,234	$1,000,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0.13%	56,064	$788,000	—	31 Mar 2018	13F
P.A.W. CAPITAL CORP	13F	Company	0.07%	30,000	$422,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.05%	23,307	$327,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.05%	22,275	$313,000	—	31 Mar 2018	13F
Virtu Financial LLC	13F	Company	0.04%	16,544	$232,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	16,300	$230,000	—	31 Mar 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	13,573	$191,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	11,429	$159,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.02%	10,597	$149,000	—	31 Mar 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.02%	7,669	$107,000	—	31 Mar 2018	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	5,697	$80,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	5,094	$72,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0.01%	3,695	$52,000	—	31 Mar 2018	13F
STRS OHIO	13F	Company	0.01%	2,500	$35,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0%	1,843	$26,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0%	1,795	$25,000	—	31 Mar 2018	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1,737	$24,405	—	31 Mar 2018	13F
Legal & General Group Plc	13F	Company	0%	1,559	$22,000	—	31 Mar 2018	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	752	$11,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	660	$9,000	—	31 Mar 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	413	$6,000	—	31 Mar 2018	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	120	$2,000	—	31 Mar 2018	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0%	92	$2,000	—	31 Mar 2018	13F

Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2018

As of 30 Jun 2018, Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,148,586 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Nantahala Capital Management, LLC, STATE STREET CORP, First Eagle Investment Management, LLC, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, MORGAN STANLEY, and TIAA CREF INVESTMENT MANAGEMENT LLC. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.